Journal of the American Geriatrics Society
The "Reducing Inflammation for Greater Health Trial (RIGHT)" Study-Concept, Rationale, and Design.
Sebastian E Sattui, Marnie Bertolet, Daniel E Forman, Michelle E Danielson, Shanshan Yao, Oscar L Lopez, Nancy W Glynn, Neelesh K Nadkarni, Akira Sekikawa, Tullia C Bruno, Toren Finkel, Anne B Newman
Published: 202610.1111/jgs.70272
Abstract
The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single-center, randomized, double-blind, placebo-controlled trial designed to test whether clazkizumab, an interleukin-6 (IL-6) inhibitor, can improve or slow decline in physical…
Preview only. Read the full abstract at the source